Frontlight ResearchEarly access
Aplastic anaemia trials in United States
24 of 36 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peoplePacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
- Where
- Bethesda
- Age
- 12 years to 120 years
- People
- 160
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06303193 - Phase 2Taking peopleAllogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- Where
- Baltimore, Bethesda
- Age
- 4 years to 80 years
- People
- 120
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT01174108 - Phase 1/2Taking peopleA Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
- Where
- Atlanta, Cleveland, Columbus, Duarte, Fairfax, Houston, Miami, New York, Palo Alto, Seattle
- Age
- 18 years and over
- People
- 60
- Run by
- Dren Bio
See details and how to joinNCT07712562 - Phase 2Taking peopleHaplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 56
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03520647 - Phase 2Taking peopleAlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- Where
- Valhalla
- Age
- 1 day to 30 years
- People
- 20
- Run by
- Mitchell Cairo
See details and how to joinNCT04099966 - Phase 2Taking peopleHaploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia
- Where
- Atlanta
- Age
- 1 year to 75 years
- People
- 20
- Run by
- Northside Hospital, Inc.
See details and how to joinNCT02828592 - Early phase 1Taking peopleDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
- Where
- Baltimore
- Age
- 18 years and over
- People
- 8
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06398457 - Phase 1/2Taking peopleUnrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- Where
- Bethesda
- Age
- 4 years to 75 years
- People
- 37
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT03173937 - Phase 2Taking peopleHaploidentical HCT for Severe Aplastic Anemia
- Where
- Memphis
- Age
- Up to 21 years
- People
- 21
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT04558736 - Phase 2Taking peopleTCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- Where
- St. Petersburg
- Age
- 0 years to 21 years
- People
- 17
- Run by
- Johns Hopkins All Children's Hospital
See details and how to joinNCT04356469 - Phase 2Taking peopleMethylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 140
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01624805 - Phase 1/2Not yet taking people in United StatesPrenatal Transplantation for Fetuses With Fanconi Anemia
- Where
- San Francisco, Stanford
- People
- 12
- Run by
- Agnieszka Czechowicz
See details and how to joinNCT07408583 - No phaseTaking peopleLet's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
- Where
- St Louis
- Age
- 8 years and over
- People
- 60
- Run by
- Washington University School of Medicine
See details and how to joinNCT06689800 - Phase 2Taking peopleMT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- Where
- Minneapolis
- Age
- 0 years to 75 years
- People
- 60
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT06412497 - Phase 1/2Taking peoplePhase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
- Where
- Philadelphia
- Age
- 1 month to 25 years
- People
- 100
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT06839456 - Phase 2Taking peopleEarly Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)
- Where
- Bethesda
- Age
- 3 years to 99 years
- People
- 80
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT04304820 - Phase 2Taking peopleClinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
- Where
- Atlanta, Baltimore, Birmingham, Boston, Chapel Hill, Charlotte, Columbus, Detroit, Duarte, Durham, Los Angeles, Milwaukee, Nashville, New York, Oklahoma City, Philadelphia, Rochester, Salt Lake City, Seattle, Stanford, St Louis, Tampa, Westwood
- Age
- 3 years to 75 years
- People
- 60
- Run by
- Medical College of Wisconsin
See details and how to joinNCT06517641 - Phase 2Taking peopleAlpha/Beta TCD HCT in Patients With Inherited BMF Disorders
- Where
- Minneapolis
- Age
- Up to 65 years
- People
- 48
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT03579875 - Phase 1Taking peopleA Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia
- Where
- Duarte
- Age
- Up to 75 years
- People
- 6
- Run by
- City of Hope Medical Center
See details and how to joinNCT05757310 - Phase 2Taking peopleA Study of Emapalumab for Pediatric Aplastic Anemia
- Where
- Cincinnati, Milwaukee, New York, Philadelphia, Richmond
- Age
- 0 years to 25 years
- People
- 35
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06430788 - Phase 2Taking peopleReduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- Where
- Pittsburgh
- Age
- 2 months to 55 years
- People
- 100
- Run by
- Paul Szabolcs
See details and how to joinNCT01962415 - Phase 2Taking peopleExercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
- Where
- Duarte, Memphis, Philadelphia
- Age
- 10 years to 30 years
- People
- 80
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05194397 - Phase 2Taking peopleRegenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
- Where
- Baltimore
- Age
- 4 months to 50 years
- People
- 27
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT04232085 - Phase 2Taking peopleTwo Step Haplo With Radiation Conditioning
- Where
- Philadephia
- Age
- 18 years and over
- People
- 63
- Run by
- Thomas Jefferson University
See details and how to joinNCT05031897